A comparison between 2- and 3-dimensional approaches to solid component measurement as radiological criteria for sublobar resection in lung adenocarcinoma ≤ 2 cm in size.


Journal

Surgery today
ISSN: 1436-2813
Titre abrégé: Surg Today
Pays: Japan
ID NLM: 9204360

Informations de publication

Date de publication:
Oct 2019
Historique:
received: 31 01 2019
accepted: 20 03 2019
pubmed: 11 4 2019
medline: 7 2 2020
entrez: 11 4 2019
Statut: ppublish

Résumé

We compared three-dimensional (3D) and two-dimensional (2D) measurements of the solid component to determine radiological criteria for sublobar resection of lung adenocarcinoma ≤ 2 cm in size. We included 233 surgical cases. The maximum size of the solid component for 3D measurement was calculated by delineating the solid component on successive axial images and reconstructing the 3D surface model. The predictive performance for adenocarcinoma in situ (n = 43) and minimally invasive adenocarcinoma (n = 77) were equivalent to areas under the curve of 0.871 and 0.857 for 2D and 3D measurements (p = 0.229), respectively. A solid component of 5 mm had a prognostic impact on both measurements ( ≤ 5 mm versus > 5 mm; p = 0.003 for 2D and p = 0.002 for 3D, log-rank test). Survival rates at 5 years were 94.7-96.9% following lobectomy and sublobar resection among patients with a solid component ≤ 5 mm in size. Sublobar resection resulted in worse survival rates, with declines at 5 years of 15.8% on 2D and 11.5% on 3D measurements, than lobectomy in patients with a solid component > 5 mm in size. A solid component ≤ 5 mm in size is an appropriate criterion for sublobar resection for both measurements. In addition, 2D measurement is justified because of its simple implementation.

Identifiants

pubmed: 30968225
doi: 10.1007/s00595-019-01806-9
pii: 10.1007/s00595-019-01806-9
doi:

Substances chimiques

Glycosides 0
Pregnanes 0
retrospinoside 0

Types de publication

Comparative Study Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

828-835

Subventions

Organisme : Japan Surgical Society
ID : Young Researcher Award in 2013

Références

J Thorac Oncol. 2011 Feb;6(2):244-85
pubmed: 21252716
J Thorac Oncol. 2011 Apr;6(4):751-6
pubmed: 21325976
J Thorac Oncol. 2014 Jan;9(1):74-82
pubmed: 24346095
J Clin Oncol. 2014 Aug 10;32(23):2403-4
pubmed: 24982454
J Thorac Oncol. 2015 Feb;10(2):237-49
pubmed: 25611226
J Thorac Oncol. 2015 Jul;10(7):990-1003
pubmed: 26134221
J Thorac Oncol. 2015 Sep;10(9):1240-1242
pubmed: 26291007
J Thorac Oncol. 2016 Aug;11(8):1204-1223
pubmed: 27107787
Ann Thorac Surg. 2016 Aug;102(2):407-15
pubmed: 27177840
Gen Thorac Cardiovasc Surg. 2017 May;65(5):273-279
pubmed: 28243892
Ann Thorac Surg. 1995 Sep;60(3):615-22; discussion 622-3
pubmed: 7677489

Auteurs

Yukihiro Yoshida (Y)

Department of Thoracic Surgery, The University of Tokyo Graduate School of Medicine, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan. yyoshida-tky@umin.ac.jp.

Toshiki Manaka (T)

Department of Bioengineering, The University of Tokyo Graduate School of Engineering, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan.

Jun-Ichi Nitadori (JI)

Department of Thoracic Surgery, The University of Tokyo Graduate School of Medicine, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan.

Aya Shinozaki-Ushiku (A)

Department of Pathology, The University of Tokyo Graduate School of Medicine, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan.

Takehito Doke (T)

Department of Bioengineering, The University of Tokyo Graduate School of Engineering, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan.

Toki Saito (T)

Department of Clinical Information Engineering, The University of Tokyo Graduate School of Medicine, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan.

Jiro Sato (J)

Department of Radiology, The University of Tokyo Graduate School of Medicine, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan.

Tempei Miyaji (T)

Department of Clinical Trial Data Management, The University of Tokyo Graduate School of Medicine, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan.

Takuhiro Yamaguchi (T)

Department of Clinical Trial Data Management, The University of Tokyo Graduate School of Medicine, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan.

Hiroshi Oyama (H)

Department of Clinical Information Engineering, The University of Tokyo Graduate School of Medicine, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan.

Masashi Fukayama (M)

Department of Pathology, The University of Tokyo Graduate School of Medicine, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan.

Yoshikazu Nakajima (Y)

Department of Bioengineering, The University of Tokyo Graduate School of Engineering, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan.

Jun Nakajima (J)

Department of Thoracic Surgery, The University of Tokyo Graduate School of Medicine, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH